...
首页> 外文期刊>BMC Cancer >A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database
【24h】

A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

机译:预测监测,流行病学和最终结果(SEER)数据库手术中非小细胞肺癌(NSCLC)患者死亡率的载体模型

获取原文
           

摘要

BACKGROUND:This study aimed to establish a novel nomogram prognostic model to predict death probability for non-small cell lung cancer (NSCLC) patients who received surgery..METHODS:We collected data from the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute in the United States. A nomogram prognostic model was constructed to predict mortality of NSCLC patients who received surgery.RESULTS:A total of 44,880 NSCLC patients who received surgery from 2004 to 2014 were included in this study. Gender, ethnicity, tumor anatomic sites, histologic subtype, tumor differentiation, clinical stage, tumor size, tumor extent, lymph node stage, examined lymph node, positive lymph node, type of surgery showed significant associations with lung cancer related death rate (P??0.001). Patients who received chemotherapy and radiotherapy had significant higher lung cancer related death rate but were associated with significant lower non-cancer related mortality (P0.001). A nomogram model was established based on multivariate models of training data set. In the validation cohort, the unadjusted C-index was 0.73 (95% CI, 0.72-0.74), 0.71 (95% CI, 0.66-0.75) and 0.69 (95% CI, 0.68-0.70) for lung cancer related death, other cancer related death and non-cancer related death.CONCLUSIONS:A prognostic nomogram model was constructed to give information about the risk of death for NSCLC patients who received surgery.
机译:背景:本研究旨在建立一种新颖的载体预后模型,以预测接受手术的非小细胞肺癌(NSCLC)患者的死亡概率。方法:从监测,流行病学和最终结果(SEER)数据库中收集数据美国国家癌症研究所。构建了一种载体预后模型,以预测接受手术的NSCLC患者的死亡率。结果:本研究中纳入了2004年至2014年的44,880名接受手术的患者。性别,种族,肿瘤解剖遗址,组织学亚型,肿瘤分化,临床阶段,肿瘤大小,肿瘤程度,淋巴结阶段,检查淋巴结,阳性淋巴结,手术类型与肺癌相关死亡率有重大关联(P? <?0.001)。接受化疗和放疗的患者具有显着的肺癌相关死亡率,但与显着较低的非癌症相关死亡率有关(P <0.001)。基于培训数据集的多变量模型建立了一个载体模型。在验证队列中,未调节的C折射率为0.73(95%CI,0.72-0.74),0.71(95%CI,0.66-0.75)和0.69(95%CI,0.68-0.70),用于肺癌相关死亡,其他癌症相关死亡和非癌症相关的死亡。结论,构建了预后的载体模型,提供了有关接受手术的NSCLC患者死亡风险的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号